{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:26:20Z","timestamp":1787113580512,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01510-1","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:04:02Z","timestamp":1787112242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reshaping addiction harm reduction program in Iran: The Ministry of Health\u2019s journey from reactive measures to strategic optimization"],"prefix":"10.1186","volume":"23","author":[{"given":"Hamid Reza","family":"Fathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Zarafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Hajebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ebrahim","family":"Ghoddousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghobad","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Shalbafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"1","key":"1510_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12954-025-01200-4","volume":"22","author":"I Jeziorska","year":"2025","unstructured":"Jeziorska I, Martinelli TF, Kools J-P. 50 years of harm reduction in Europe: high time for transformation. Harm Reduct J. 2025;22(1):94.","journal-title":"Harm Reduct J"},{"key":"1510_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.drugpo.2014.11.007","volume":"26","author":"DP Wilson","year":"2015","unstructured":"Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26:S5\u201311.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1510_CR3","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1007\/s11606-021-06904-4","volume":"36","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. Integrating harm reduction into outpatient opioid use disorder treatment settings: harm reduction in outpatient addiction treatment. J Gen Intern Med. 2021;36(12):3810\u20139.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"1510_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00441-9","volume":"18","author":"A Rajabi","year":"2021","unstructured":"Rajabi A, Sharafi H, Alavian SM. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis. Harm Reduct J. 2021;18(1):12.","journal-title":"Harm Reduct J"},{"issue":"9","key":"1510_CR5","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s10461-022-03627-3","volume":"26","author":"M Khezri","year":"2022","unstructured":"Khezri M, Shokoohi M, Mirzazadeh A, Tavakoli F, Ghalekhani N, Mousavian G, et al. HIV prevalence and related behaviors among people who inject drugs in Iran from 2010 to 2020. AIDS Behav. 2022;26(9):2831\u201343.","journal-title":"AIDS Behav"},{"key":"1510_CR6","unstructured":"Center for Communicable Diseases Control, Ministry of Health and Medical Education. National HIV\/AIDS surveillance report, 1403 [2024\/25]. Tehran: Iran CDC; 2024. [In Persian]."},{"issue":"2","key":"1510_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/dar.12014","volume":"32","author":"S Shariatirad","year":"2013","unstructured":"Shariatirad S, Maarefvand M, Ekhtiari H. Emergence of a methamphetamine crisis in Iran. Drug Alcohol Rev. 2013;32(2):223\u20134.","journal-title":"Drug Alcohol Rev"},{"key":"1510_CR8","first-page":"6578","volume":"12","author":"A Rastegari","year":"2023","unstructured":"Rastegari A, Baneshi MR, Hajebi A, Noroozi A, Karamouzian M, Shokoohi M, et al. Population size estimation of people who use illicit drugs and alcohol in Iran (2015\u20132016). Int J Health Policy Manag. 2023;12:6578.","journal-title":"Int J Health Policy Manag"},{"issue":"1","key":"1510_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23558-7","volume":"25","author":"N Ghalekhani","year":"2025","unstructured":"Ghalekhani N, Hajebi A, Ghodusi E, Beygi B, Khojasteh Bojnordi T, Mashhour MF, et al. Programmatic mapping and size estimation of people who inject drugs to plan targeted HIV prevention and harm reduction programs in Iran, a nationwide study. BMC Public Health. 2025;25(1):2428.","journal-title":"BMC Public Health"},{"issue":"4","key":"1510_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/14659891.2022.2077247","volume":"28","author":"M Khodadost","year":"2023","unstructured":"Khodadost M, Ghalekhani N, Hajebi A, Gouya MM, Afsar Kazerooni P, Ghoddousi SE, et al. Mapping and size estimation of people who inject drugs: an innovative approach for targeted harm reduction program in Iran. J Subst Use. 2023;28(4):588\u201396.","journal-title":"J Subst Use"},{"issue":"2","key":"1510_CR11","doi-asserted-by":"publisher","DOI":"10.5812\/ijpbs.7730","volume":"11","author":"SR Radfar","year":"2017","unstructured":"Radfar SR, Mohsenifar S, Noroozi A. Integration of methamphetamine harm reduction into opioid harm reduction services in Iran: preliminary results of a pilot study. Iran J Psychiatry Behav Sci. 2017;11(2):e7730.","journal-title":"Iran J Psychiatry Behav Sci"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01510-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:04:03Z","timestamp":1787112243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01510-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01510-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial competing interests. Several authors are affiliated with the Ministry of Health and Medical Education and have been involved in the design, implementation, and\/or supervision of Iran's national harm reduction program. This constitutes a non-financial interest that readers should consider when interpreting this reflective account.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"138"}}